DoubleVerify Holdings, Inc. DV 深 滬
等待開盤 06-25 09:30:00 美东时间
10.35
-0.090
-0.86%
華盛通- 最 高10.675
- 今 開10.40
- 成交量 254.12万股
- 最 低 10.34
- 昨 收 10.44
- 總市值 15.88亿
- 52周最高 16.82
- 市盈率 靜 34.06
- 換手率 1.66%
- 52周最低 7.64
- 委 比 -29.95%
- 總股本 1.53亿
- 歷史最高 48.42
- 量 比 0.95
- 振 幅 3.21%
- 歷史最低 7.64
- 每 手 1
- 風險率 2.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多DoubleVerify将DV Authentic AdVantage扩展至Meta与TikTok 推出优化媒体质量与效果的人工智能解决方案
2026年6月22日，纽交所上市媒体效能平台DoubleVerify（DV，股票代码DV）宣布将旗下DV Authentic AdVantage™解决方案的服务...
06-22 14:11
DoubleVerify Expands DV Authentic AdVantage to Meta and TikTok, an AI-Powered Solution to Optimize Media Quality and Performance
DoubleVerify expands DV Authentic AdVantage to Meta and TikTok, offering integrated pre-bid protection, AI-powered optimization, and independent measurement to enhance ad performance, media quality, and efficiency. The solution eliminates tradeoffs between cost, quality, and outcomes, providing advertisers with unified insights and maximizing campaign effectiveness. Early results on TikTok show significant improvements, including 98% increase in ...
06-22 04:01
DoubleVerify Launches AI-Powered Brand Suitability Reporting For YouTube Audio Ads Campaign
As advertisers increasingly allocate dedicated budgets to audio environments, the need for transparency and control continues to grow. With brand suitability reporting for YouTube Audio Ads campaigns, DV helps customers confidently expand into this media category, applying consistent standards and g...
06-11 20:06
DoubleVerify Launches AI-Powered Brand Suitability Reporting for YouTube Audio Ads Campaigns, Expanding Transparency in Listening-First Environments
DoubleVerify (DV) has introduced AI-powered brand suitability reporting for YouTube Audio Ads, enhancing transparency and control in audio advertising. This service leverages DV's Universal Content Intelligence™ to analyze audio content, ensuring alignment with brand standards. The solution is part of DV's Media AdVantage Platform, designed to optimize campaign performance and maximize media effectiveness.
06-11 12:00
Comscore appoints Matt McLaughlin as CEO
Comscore (SCOR) on Thursday announced the appointment of Matt McLaughlin as Chief Executive Officer of the company, effective immediately. Jon Carpenter will transition from his role as CEO and will ...
05-29 04:36
DoubleVerify Delivers Global Media Quality Measurement for LinkedIn Audience Network, Elevating Transparency for B2B Advertisers
DoubleVerify (DV) has launched global post-bid measurement capabilities on the LinkedIn Audience Network (LAN), enabling advertisers to measure key media quality signals such as invalid traffic, viewability, brand suitability, and intended geography. This independent verification empowers advertisers to make informed investment decisions and improve campaign effectiveness. DV’s solution also offers pre-bid controls for proactive inventory analysi...
05-21 13:00
DoubleVerify Launches AI-Powered Content-Level Controls on Meta Threads, Strengthening Brand Protection
DoubleVerify (DV) introduces AI-powered pre-screen content controls on Meta Threads, enabling advertisers to avoid unsuitable content before ads are served. This enhances brand protection and improves campaign performance. DV’s pre-screen controls evaluate content before impressions are transacted, helping advertisers avoid placements that fall below their defined brand suitability thresholds. Post-bid measurement then analyzes delivered impressi...
05-18 13:00
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
DoubleVerify expands Philippines team in APAC investment push
DoubleVerify expands Philippines team in APAC investment push DoubleVerify expanded investment in Philippines with a larger local team, reinforcing broader push across Asia-Pacific. Expansion added two Manila-based hires, including Integrated Solutions Director Jeff Orpilla, to support brands, agenc
05-12 12:05
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
